Ketan Patel | |
|---|---|
 Patel in 2019 | |
| Born | Ketan Rajnibhai Patel |
| Alma mater |
|
| Occupation | Pharmacist, businessman |
Ketan Patel is an Indian pharmacist, innovator, and serves as the chairman & managing director of Troikaa Pharmaceuticals, a pharmaceutical company headquartered in Gujarat, India.[1]
Patel is the chairman of the Board of Governors at National Institute of Pharmaceutical Education & Research (NIPER), Gandhinagar.[2]
Education & career[edit | edit source]
Patel earned Gold Medals during both his Bachelor of Pharmacy and Master of Pharmacy programs from L. M. College of Pharmacy, Ahmedabad. He received a Ph.D. in Pharmaceutical Technology, which he obtained from Dharamsinh Desai University, Gujarat.[3]
Patel established the "Rajnibhai.V. Patel Pharmlnnova Award" under the aegis of the Department of Science and Technology (India).[4][5]
Details of his career are documented in the book titled 'THE INNOVATORS,' published by the Department of Science and Technology (India) Government of India.[6]
Invention[edit | edit source]
Patel is the primary inventor and patent holder of a painless diclofenac injection marketed under the brand name 'DYNAPAR-AQ' by Troikaa Pharmaceuticals Ltd. His innovation earned recognition from the Government of India’s Department of Science & Industrial Research, which honored him with the National Award in 2008.[7][8]
In 2008, he invented a quick, powerful & long-lasting penetrating solution of Diclofenac designed for Topical administration known as “Dynapar QPS”, for which he was conferred with a National Award in 2015 from the Department of Science & Technology, Govt of India.[9]
In 2019, he introduced a solution for Vitamin B12 deficiency. NasoB12, the world's first globally approved nasal drug delivery system, utilizes Methylcobalamin, the biologically active form of Vitamin B12, to effectively address Vitamin B12 deficiency, which has high prevalence in India and developing nations. NASO B12 was honored with the "India Star Award" for outstanding packaging design. This award was provided by the Indian Institute of Packaging, an autonomous body operating under the aegis of the Ministry of Commerce and Industry, Government of India.[10][11]
In 2023, Xykaa IM, world’s first 500 mg Paracetamol/2ml injection was introduced by Ketan Patel and Milan Patel.[12][13]
Awards and honors[edit | edit source]
- National Award by Department of Scientific & Industrial Research (DSIR) in 2011, facilitated by former President of India – A.P.J. Abdul Kalam for R&D efforts
References[edit | edit source]
- ↑ Talukdar, Tapash (8 September 2008). "The pain killer". The Economic Times.
- ↑ "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". indiankanoon.org.
- ↑ "L M COLLEGE OF PHARMACY M.PHARM. ALUMNI (1956-2013)" (PDF). lmcp.in. Archived from the original (PDF) on 2018-07-13. Retrieved 2019-12-20.
- ↑ "Award" (PDF). .tnmgrmu.ac.in.
- ↑ "Home : PharmInnova Award". www.innovativethesisaward.org. Archived from the original on 2020-02-04. Retrieved 2019-12-20.
- ↑ Awasthi, Dinesh Narain; Joshi, Rajiv (2015). The Innovators: Stories of Hi-tech Entrepreneurs. Centre for Policy Research in Science & Technology Entrepreneurship, Entrepreneurship Development Institute of India. ISBN 978-93-80574-84-4.
- ↑ "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". Indiankanoon.
- ↑ "Injectable preparations of diclofenic and its pharmaceutically acceptable salts". Patent Google. 30 January 2006.
- ↑ "A non-aqueous topical solution of diclofenac and process for preparing the same".
- ↑ "Troikaa Pharma with its indigenised B12 nasal spray sees doctors prefer simple ways to offset B-12 deficiency". Pharmabiz.
- ↑ "WIPO - Search International and National Patent Collections". patentscope.wipo.int.
- ↑ "DPCO impact: Revenue of local pharma players may dip". Business Standard.
- ↑ "WO2012001494 - PHARMACEUTICAL COMPOSITIONS COMPRISING PARACETAMOL AND PROCESS FOR PREPARING THE SAME". patentscope.wipo.int.